NCT03566966View on ClinicalTrials.gov

Autoantibodies and Direct-acting Antivirals

CompletedOBSERVATIONAL
Enrollment

191

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

March 31, 2017

Conditions
Viral Hepatitis CTherapy Adverse Effect
Interventions
BIOLOGICAL

Non-organ-specific Ab positive

Antiviral administration and evaluation of SVR24 and side effects

BIOLOGICAL

Non-organ-specific Ab negative

direct-acting antiviral agents

Trial Locations (1)

70124

Policlinic Hospital, Bari

All Listed Sponsors
lead

University of Bari

OTHER

NCT03566966 - Autoantibodies and Direct-acting Antivirals | Biotech Hunter | Biotech Hunter